Replimune (REPL) has announced that it has no other option but to reduce its workforce and scale back U.S. manufacturing operations after the FDA on Friday declined to approve its lead asset, RP1, ...

FDA has now rejected Replimune’s melanoma immunotherapy RP1 on two separate occasions The drug was under consideration for use with Bristol Myers Squibb’s (BMY) Opdivo therapy Regulators maintained ...

Though the original Resident Evil movies starring Milla Jovovich certainly found an audience, for many fans of the long-running survival horror video game series, we still haven't had a really great ...

President Trump on Wednesday claimed there was “nothing left” to bomb in Iran and that the war would end soon, the latest of what has often been conflicting messaging on the timeline of the conflict.

WASHINGTON, March 11 (Reuters) - U.S. President Donald Trump told Axios on Wednesday that there's "practically nothing left" to target in Iran ⁠and that the war there will end "soon." "Little this and ...

Abstract: Generating high-performance tensor programs on resource-constrained devices is challenging for current Deep Learning (DL) compilers that use learning-based cost models to predict the ...

A monthly overview of things you need to know as an architect or aspiring architect. Unlock the full InfoQ experience by logging in! Stay updated with your favorite authors and topics, engage with ...

Amid a push toward AI agents, with both Anthropic and OpenAI shipping multi-agent tools this week, Anthropic is more than ready to show off some of its more daring AI coding experiments. But as usual ...

In case you've faced some hurdles solving the clue, Practically forever, we've got the answer for you. Crossword puzzles offer a fantastic opportunity to engage your mind, enjoy leisure time, and test ...